SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11421883
Source:
http://linkedlifedata.com/resource/pubmed/id/11421883
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0079488
,
umls-concept:C0087111
,
umls-concept:C0205132
,
umls-concept:C0205175
,
umls-concept:C0205349
,
umls-concept:C1710063
pubmed:issue
7
pubmed:dateCreated
2001-6-25
pubmed:abstractText
Cure rates of 7-day triple therapy seem to be decreasing. Quadruple therapies may be an alternative, although their complex administration makes patient acceptance difficult.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole
,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole
,
http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/Tetracycline
,
http://linkedlifedata.com/resource/pubmed/chemical/bismuth tripotassium dicitrate
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0269-2813
pubmed:author
pubmed-author:BrulletEE
,
pubmed-author:CalvetXX
,
pubmed-author:CampyDD
,
pubmed-author:GarciaNN
,
pubmed-author:GerlDD
,
pubmed-author:SanfeliuII
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1061-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11421883-Administration, Oral
,
pubmed-meshheading:11421883-Adult
,
pubmed-meshheading:11421883-Aged
,
pubmed-meshheading:11421883-Anti-Bacterial Agents
,
pubmed-meshheading:11421883-Anti-Ulcer Agents
,
pubmed-meshheading:11421883-Drug Administration Schedule
,
pubmed-meshheading:11421883-Drug Therapy, Combination
,
pubmed-meshheading:11421883-Female
,
pubmed-meshheading:11421883-Helicobacter Infections
,
pubmed-meshheading:11421883-Helicobacter pylori
,
pubmed-meshheading:11421883-Humans
,
pubmed-meshheading:11421883-Male
,
pubmed-meshheading:11421883-Metronidazole
,
pubmed-meshheading:11421883-Middle Aged
,
pubmed-meshheading:11421883-Omeprazole
,
pubmed-meshheading:11421883-Organometallic Compounds
,
pubmed-meshheading:11421883-Patient Compliance
,
pubmed-meshheading:11421883-Peptic Ulcer
,
pubmed-meshheading:11421883-Tetracycline
,
pubmed-meshheading:11421883-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.
pubmed:affiliation
Department of Surgery, Corporació Sanitária Parc Taulí, Sabadell, Spain. xcalvet@cspt.es
pubmed:publicationType
Journal Article
,
Clinical Trial